NCT03429816 2025-03-27
OPPOSITE
University Hospital Heidelberg
Phase NA Completed
Clinical Trials
3 trialsNCT02332213 2018-08-21
VOLGACORE
University of Latvia
Completed
NCT00397904 2015-11-25
Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and Cisplatin
Memorial Sloan Kettering Cancer Center
Phase 2 Completed